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Results: The time for the optimization and the final dose 
calculation was less than 5 minutes for each plan having a 
total of 21 fields (7 groups of 3 heads). The mean CV for the 
conformity index was found to be equal to 1.6±0.5% whilst 
both the mean V95(PTV1) and the HI resulted in a CV smaller 
than 1%. The CV for the estimated beam-on time for the 10 
patients was found to be 4.3±2.1% (mean±std). 
 
Conclusion: MRI-guided radiotherapy is a novel approach that 
may be advantageous over current treatment techniques by 
allowing PTV reduction. Dose optimization and calculation 
time is done with full Monte Carlo with a very short 
calculation time. 
The three plan parameters under consideration proved that 
the Monte Carlo dose calculation is stable with a difference 
of the order of 4% in the estimated beam-on time.  
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Purpose or Objective: Spine SBRT is an emerging treatment 
for patients with spinal metastases and rapidly being adopted 
in the clinic without treatment planning evaluation 
guidelines. Although the a priori treatment planning 
constraints were met in all cases in our previous study, large 
inter-institutional variations in 95% of the PTV volume (D95) 
and D50 were observed. The purpose of this study was to 
minimize the inter-institutional variations in planning. 
 
Material and Methods: Seven institutions in Japan, Canada, 
Singapore and USA participated and planned three cases with 
a total of ten apparatus. The spine cases included a 5th 
lumbar spine (case 1), 5th thoracic spine (case 2), and 10th 
thoracic spine metastases (case 3). Targets and organs at risk 
(OAR) were contoured by one experienced radiation 
oncologist according to International Spine Radiosurgery 
Consortium Consensus Guidelines and a 2 mm planning target 
volume (PTV) applied. The DICOM files were sent to each 
institute for planning. The treatment planning guidelines in 
the previous study included, prescribed dose of 24 Gy in two 
fractions with more than 70% prescribed dose to encompass 
D95, D0.035 &lt; 140% of the prescribed dose, and a 
maximum dose to the spinal cord planning organ at risk 
volume (PRV) or thecal sac &lt; 17 Gy. New guidelines added 
(D95 should be as high as possible(AHAP), D50 should be 
between 110% to 115% of prescribed dose and AHAP and 
D0.035 should be between 125% to 135% of the prescribed 
dose). The dose volume histograms (DVHs) were centrally 
reviewed. 
 
Results: In our previous study the PTV D95 ranged from 70.0% 
to 99.6 % in case 1 (mean &plusmn; SD; 21.21 &plusmn; 2.43 
Gy), 70.4% to 98.8% in case 2 (20.32 &plusmn; 2.22 Gy), and 
70.0% to 94.2% in case 3 (19.78 &plusmn; 1.97 Gy), 
respectively and D50 for PTV ranged from 99.2% to 116.3% in 
case 1 (25.62 &plusmn; 1.34 Gy), 91.7% to 119.6% in case 2 
(25.97 &plusmn; 2.18 Gy) and 84.2% to 114.2% in case 3 
(25.57 &plusmn; 2.14 Gy), respectively. In this study PTV D95 
ranged from 80.4% to 100.0% in case 1 (21.96 &plusmn; 1.67 
Gy), 76.3% to 95.8% in case 2 (20.91 &plusmn; 1.67 Gy), and 
70.4% to 94.2% in case 3 (20.3 &plusmn; 1.86 Gy), 
respectively and D50 for PTV ranged from 109.6% to 115.4% in 
case 1 (27.02 &plusmn; 0.53 Gy), 110.0% to 117.5% in case 2 
(27.06 &plusmn; 0.63 Gy) and 107.5% to 115.0% in case 3 
(26.89 &plusmn; 0.67 Gy), respectively. 
 
Conclusion: We succeeded to minimize the inter-institutional 
variations. This study highlights dose constraints of D95, D50 
and D0.035 should be used to minimize the variations. 
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Purpose or Objective: The use of nanoparticles (NP) in 
cancer therapy has been intensively investigated in the last 
few years. The advantage of using metal NP (such as gold, 
platinum, silver, hafnium oxide) during radiotherapy is that 
the amount of secondary electrons produced by the primary 
particles is higher than for soft tissue. Due to this enhanced 
secondary-electron emission around NP, stronger DNA 
damage is caused in the surrounding cells. The enhancement 
of energy deposition around gold NP has been determined in 
a number of studies, often with contradictory results, thus 
showing that the absorbed dose is not the appropriate 
physical quantity to estimate DNA damage in the presence of 
gold. Therefore it is necessary to systematically investigate 
the dependence of DNA damage from the spectra of the 
emitted secondary electrons and from corresponding 
nanodosimetric parameters. 
 
Material and Methods: In this work, the secondary electron 
spectra produced inside and around gold NP were determined 
by means of Monte-Carlo simulations. The transport of 
secondary electrons created by different clinical photon 
sources inside and emerging from a NP surrounded by water 
was simulated using Geant4. The secondary electron 
spectrum inside gold NP of two different sizes (diameter: 12 
and 30 nm) was calculated for mono-energetic photon 
sources (10 and 60 keV), an intra-operative x-ray source 
(maximum energy 50 keV), a conventional x-ray tube (200 
keVp) and a clinical linear accelerator (6 MV).  
 
Results: The energy spectra of the secondary electrons 
created inside the NP have a mean energy varying between 
about 6 keV for the mono-energetic 10-keV photons and 
about 65 keV for the 6-MV spectrum. This corresponds to a 
decrease of the mean ionization cluster size of about a factor 
of four for the linear accelerator. Therefore a corresponding 
decrease of the number of induced DNA double strand breaks 
is expected. Moreover, the spectra inside and around the 
gold NP with a diameter of 12 nm barely distinguish from 
those inside the gold NP with a diameter of 30 nm. However, 
the total amount of secondary electrons emerging from the 
smaller gold NP is increased by about a factor of three.  
 
Conclusion: Further studies will be carried out in the future 
for determining the correlation between secondary electrons 
production and ionization cluster size distributions for other 
NP diameters and materials. Finally, a comparison between 
physical damage at nanometric level and cell survival 
experiments will be also performed.  
 
 
